Spots Global Cancer Trial Database for deficient mismatch repair system (dmmr)
Every month we try and update this database with for deficient mismatch repair system (dmmr) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Pembrolizumab With Sitravatinib in Recurrent Endometrial Cancer and Other Solid Tumors With Deficient Mismatch Repair System | NCT05419817 | Recurrent Endom... Solid Tumors | pembrolizumab Sitravatinib | 18 Years - | University of Pittsburgh |